BACKGROUND: The prognostic role of serum C-reactive protein in pancreatic cancer has received increasing attention; however the confounding effects of biliary obstruction have not been addressed in previous studies. We sought to determine the prognostic importance of serum CRP prior to biliary intervention in the prognosis of pancreatic adenocarcinoma. METHODS: A retrospective case note review of patients diagnosed with pancreatic cancer between 2001 and 2006. Clinical, radiological and biochemical criteria were correlated with overall survival. Patients were divided into: Group 1 who underwent potentially curative resection, and Group 2 with advanced unresectable disease managed non-surgically. RESULTS: In total, 199 patients were included (58 resected). The proportion of patients with biliary obstruction was equal in both groups. Serum CRP and serum bilirubin concentration at presentation were significantly higher among patients in Group 2 compared to Group 1 (P values). On multivariate analysis, advancing age (P=0.012) and raised serum CRP concentration were independently associated with overall survival only in Group 2 patients (P=0.027, 95% CI 0.31-0.93). This association was independent of biliary tract obstruction. CONCLUSION: Raised serum C-reactive protein concentration at the time of presentation of advanced pancreatic cancer carries a poor prognosis independent of biliary tract obstruction.
BACKGROUND: The prognostic role of serum C-reactive protein in pancreatic cancer has received increasing attention; however the confounding effects of biliary obstruction have not been addressed in previous studies. We sought to determine the prognostic importance of serum CRP prior to biliary intervention in the prognosis of pancreatic adenocarcinoma. METHODS: A retrospective case note review of patients diagnosed with pancreatic cancer between 2001 and 2006. Clinical, radiological and biochemical criteria were correlated with overall survival. Patients were divided into: Group 1 who underwent potentially curative resection, and Group 2 with advanced unresectable disease managed non-surgically. RESULTS: In total, 199 patients were included (58 resected). The proportion of patients with biliary obstruction was equal in both groups. Serum CRP and serum bilirubin concentration at presentation were significantly higher among patients in Group 2 compared to Group 1 (P values). On multivariate analysis, advancing age (P=0.012) and raised serum CRP concentration were independently associated with overall survival only in Group 2 patients (P=0.027, 95% CI 0.31-0.93). This association was independent of biliary tract obstruction. CONCLUSION: Raised serum C-reactive protein concentration at the time of presentation of advanced pancreatic cancer carries a poor prognosis independent of biliary tract obstruction.
Authors: Wilson Petrushnko; Justin S Gundara; Philip R De Reuver; Greg O'Grady; Jaswinder S Samra; Anubhav Mittal Journal: HPB (Oxford) Date: 2016-07-14 Impact factor: 3.647
Authors: Abby K Geletzke; John M Rinaldi; Brett E Phillips; Sarah B Mobley; Jamie Miller; Thomas Dykes; Christopher Hollenbeak; Shannon L Kelleher; David I Soybel Journal: J Gastrointest Surg Date: 2013-12-20 Impact factor: 3.452
Authors: Jason B Douglas; Debra T Silverman; Stephanie J Weinstein; Barry I Graubard; Michael N Pollak; Yuzhen Tao; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-12-20 Impact factor: 4.254
Authors: Lewis Stevens; Samir Pathak; Quentin M Nunes; Sanjay Pandanaboyana; Christian Macutkiewicz; Neil Smart; Andrew M Smith Journal: HPB (Oxford) Date: 2014-11-27 Impact factor: 3.647
Authors: Ondrej Fiala; Milos Pesek; Jindrich Finek; Ondrej Topolcan; Jaroslav Racek; Marek Minarik; Lucie Benesova; Zbynek Bortlicek; Alexandr Poprach; Tomas Buchler Journal: Tumour Biol Date: 2015-06-19
Authors: Marcel C G van de Poll; Yvonne L B Klaver; Valery E P P Lemmens; Bart J M Leenders; Simon W Nienhuijs; Ignace H J T de Hingh Journal: Int J Colorectal Dis Date: 2011-04-08 Impact factor: 2.571
Authors: A Xue; C J Scarlett; L Chung; G Butturini; A Scarpa; R Gandy; S R Wilson; R C Baxter; R C Smith Journal: Br J Cancer Date: 2010-06-29 Impact factor: 7.640
Authors: Michael Haas; Volker Heinemann; Frank Kullmann; Rüdiger P Laubender; Christina Klose; Christiane J Bruns; Stefan Holdenrieder; Dominik P Modest; Christoph Schulz; Stefan Boeck Journal: J Cancer Res Clin Oncol Date: 2013-01-13 Impact factor: 4.553